Target intelligence / Profile preview

Bacterial carbohydrate metabolism pathways

Molecular classification
Enzyme, Transporter
01

Overview

Bacterial carbohydrate metabolism pathways encompass the biochemical processes by which bacteria transport, break down, and utilize sugars to generate energy and biosynthetic precursors. These pathways include glycolysis, the pentose phosphate pathway, the Entner-Doudoroff pathway, and the bacterial-specific phosphotransferase system (PTS) (NIH, 2014). They are essential for bacterial survival, providing ATP and carbon skeletons for the synthesis of amino acids, nucleotides, and cell wall components like peptidoglycan (PubMed, 2014). While many central metabolic enzymes have human homologs, certain bacterial-specific components, such as the methylerythritol phosphate (MEP) pathway or the PTS, are being explored as novel antimicrobial targets to minimize host toxicity (NIH, 2025). Drugs like fosfomycin already exploit these pathways by inhibiting enzymes that process sugar-derived precursors for cell wall synthesis (NIH, 2022). Targeting these pathways is a promising strategy for developing new antibiotics, though challenges include bacterial metabolic plasticity and potential disruption of the host's commensal microbiota (ASM, 2022). Overall, these pathways represent a critical Achilles' heel for pathogens, offering diverse opportunities for therapeutic intervention in the face of rising antibiotic resistance (NIH, 2014).

Other names
Bacterial central carbon metabolismBacterial sugar metabolismBacterial carbohydrate utilizationBacterial carbon metabolism
02

Mechanism of action

Inhibition of specific enzymes or transporters within the carbohydrate metabolic network to disrupt energy production, precursor supply, and cell wall integrity.

03

Biological functions

Energy productionCarbon source utilizationBiosynthesis of precursorsCell wall synthesis
04

Disease associations

Infection
05

Safety considerations

Off-target effects on human metabolic homologsMetabolic plasticity and bypass mechanismsImpact on commensal gut microbiota
06

Interacting drugs

Fosfomycin

2 more in the full profile.

07

Biomarkers

Bacterial growth rateMetabolite levels (e.g., lactate, pyruvate)Glucose uptake rates

Beyond the preview

Go deeper on Bacterial carbohydrate metabolism pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial carbohydrate metabolism pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call